Leading Growth Driver in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2025: Rising Prevalence of Glaucoma Spurs Demand for Minimally Invasive Glaucoma Surgery (MIGS) Devices Driver's Influence

What Are the Market Size and Growth Forecast for the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The market size for minimally invasive glaucoma surgery (MIGS) devices has witnessed an exponential surge in recent years. The market is projected to escalate from $0.7 billion in 2024 to $0.9 billion in 2025, hitting a compound annual growth rate (CAGR) of 28.3%. Factors such as heightened consciousness about blindness prevention, substantive investments in healthcare facilities, a growing understanding of advanced vision correction treatments by patients, and amplified awareness about sophisticated vision correction strategies, supplemented by governmental initiatives have fueled growth during the historical period.

Expectations are high for the minimally invasive glaucoma surgery (MIGS) devices market, with predictions of remarkable growth in the coming years. It's projected that the market will expand to a staggering $2.42 billion by 2029, amounting to a compound annual growth rate (CAGR) of 28.1%. This predicted rise for the forecast period can be linked to several factors including the rising incidence of eye conditions such as glaucoma, an increase in the elderly population, developments in healthcare infrastructure, and the demand for safer and more effective treatment modalities. Key trends to watch include the increased use of MIGS devices, technological advancements, the creation of innovative minimally invasive glaucoma surgery devices, the development of advanced implantable devices and progress in ophthalmic technology.

What Key Elements Are Boosting Growth in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The escalating prevalence of eye conditions is predicted to drive the progression of the minimally invasive glaucoma surgery (MIGS) devices market. This includes a myriad of issues that affect vision and eye health. The growing incidence of eye conditions can be attributed to changes in lifestyle, environmental factors, and an aging populace. MIGS devices serve as state-of-the-art tools in the treatment of a range of eye diseases, with their primary purpose being the decrease of intraocular pressure (IOP) to avert or manage the advancement of glaucoma. For example, it has been projected by the National Eye Institute, a government agency in the US, that about 2.2 million citizens will suffer from total or partial blindness by the year 2030. Hence, the escalating prevalence of eye conditions stimulates the market growth of minimally invasive glaucoma surgery (MIGS) devices.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

Which Key Market Leaders Are Driving Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry Growth?
Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.

What Are the Emerging Trends in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry?
Leading organizations in the minimally invasive glaucoma surgery (MIGS) devices marketplace are channeling their efforts into creating innovative solutions like stent injectable systems. These systems are designed to address previously unaddressed issues within the field of glaucoma management, enhancing patient results. A stent injectable system is a type of MIGS device that introduces and implants a tiny stent into the patient's body using a procedure similar to an injection, typically using a specialized instrument common in minimally invasive procedures for treating issues like obstructions or constrictions in blood vessels. In August 2022, for instance, the US-based ophthalmic medical tech firm Glaukos Corporation, got 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their product, the iStent Infinite Trabecular Micro-Bypass System. This new three-stent injectable system, the iStent Infinite, is engineered to provide a foundational, around-the-clock intraocular pressure (IOP) regulation for primary open-angle glaucoma (POAG) patients whose IOP is not properly managed by prior medication or surgical methods.

What Are the Main Segments in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The minimally invasive glaucoma surgery (MIGS) devices market covered in this report is segmented -

1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users

Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Geographic Area Leads the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Global Market Report?

- Market Size Analysis: Analyze the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Minimally Invasive Glaucoma Surgery (MIGS) Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15863

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.